AGP Picks
View all

RX-O2 teams with hyperbaric safety group on brain health study

3 hours ago
RX-O2 teams with hyperbaric safety group on brain health study
By AI, Created 21:51 UTC, Nov 17, 2026, AGP -

RX-O2 Hyperbaric Clinics is launching a Brain Health Research Program with the National Hyperbaric Safety Association to study hyperbaric oxygen therapy, cognitive function and aging in the greater Phoenix area. Older adults may contact the clinic now for screening and possible participation in a planned cohort of up to 30 people.

Why it matters: - The initiative could add new clinical evidence on whether hyperbaric oxygen therapy has any role in healthy cognitive aging. - The program is designed for older adults in the greater Phoenix area who may qualify for research participation and discounted hyperbaric oxygen therapy. - The effort also matters because hyperbaric oxygen therapy is not an established treatment for preventing cognitive decline or treating dementia.

What happened: - RX-O2 Hyperbaric Clinics partnered with the National Hyperbaric Safety Association to develop a Brain Health Research Program. - The program will examine hyperbaric oxygen therapy, cognitive function and aging. - RX-O2 is inviting older adults and families in the greater Phoenix area to contact the clinic now about eligibility, screening and possible participation. - The planned cohort is up to 30 participants, with eligibility determined through individual screening.

The details: - People interested in discounted HBOT through research participation can discuss potential opportunities, costs and participation requirements with the RX-O2 team. - An inquiry does not reserve a place or constitute study enrollment. - RX-O2 has provided hyperbaric oxygen therapy in the Valley of the Sun for more than 22 years through its Glendale and Scottsdale facilities. - The clinics have cared for patients with cognitive concerns, which helped shape the research effort. - Marvin A. Borsand, D.O., RX-O2’s medical director, is a clinical investigator for the initiative. - Borsand said observing cognitive decline among peers led him to explore the scientific literature and the potential role of hyperbaric medicine. - The program draws inspiration from work by researchers affiliated with Israel’s Sagol Center for Hyperbaric Medicine and Research at Shamir Medical Center and Tel Aviv University’s Sagol School of Neuroscience. - A 2020 randomized controlled study of 63 healthy older adults reported improvements in cognitive measures, especially attention and information-processing speed, along with changes in regional brain blood flow. - Those findings involved healthy aging adults and did not establish that HBOT prevents or treats dementia. - RX-O2 says patient stories about improved memory, mental clarity and daily function have helped sustain interest in brain health research, but those experiences alone cannot establish effectiveness. - The initiative aims to produce findings for peer-reviewed publication and a clearer picture of who may benefit, by how much and under what conditions. - Results from this initiative have not yet been published. - RX-O2’s broader research interests include healthy cognitive aging and cognitive decline associated with Alzheimer’s disease and vascular dementia. - Eligibility for people with particular diagnoses requires individual clinical screening and must meet the program’s research criteria. - Melanie Dooley, N.D., a hyperbaric physician and clinical investigator at RX-O2, brings a patient-centered approach and an interest in measurable outcomes. - Alexander Borsand, M.D., RX-O2’s clinic safety director, will support education and safety oversight. - Alexander Borsand was invited in 2025 to speak about hyperbaric oxygen therapy and cognitive enhancement at an American Academy of Anti-Aging Medicine event. - The NHSA collaboration connects the research goals with staff education and safe hyperbaric practice. - The planned program includes review of medical records, standardized cognitive assessments and follow-up. - Laboratory testing or imaging may be required, and some costs may be out of pocket. - The team says it will explain these requirements before participants commit. - Interested individuals can visit the RX-O2 brain health program page, call 480-685-9022 or email info@rx-o2.com. - The research team will review inquiries and explain next steps. - Detailed medical records should be provided only through the clinic’s designated secure process.

Between the lines: - RX-O2 is pairing a research pitch with a safety and education message, which suggests the clinic wants to position the project as both scientifically cautious and clinically accessible. - The program’s emphasis on screening, follow-up and publication signals an attempt to move from anecdotal reports toward data that can be evaluated more formally. - The repeated caution that HBOT is not proven for dementia underscores the limited evidence base even as interest in brain health therapies grows.

What’s next: - RX-O2 will screen interested older adults and family members to determine who may qualify. - The clinic will explain participation requirements, possible costs and any need for testing before enrollment decisions are made. - If the cohort is filled and the study proceeds as planned, the team expects to gather data for peer-reviewed publication.

The bottom line: - RX-O2 is trying to turn patient interest in hyperbaric oxygen therapy into a structured brain health study, but the work remains exploratory and not a proven dementia treatment.

Disclaimer: This article was produced by AGP Wire with the assistance of artificial intelligence based on original source content and has been refined to improve clarity, structure, and readability. This content is provided on an “as is” basis. While care has been taken in its preparation, it may contain inaccuracies or omissions, and readers should consult the original source and independently verify key information where appropriate. This content is for informational purposes only and does not constitute legal, financial, investment, or other professional advice.

Sign up for:

Science Press Releases

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Science Press Releases

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.